Researchers from Brigham and Women’s Hospital want to prevent alpha-synuclein from accumulating in the brain. To do so, the team searched for drugs that turn down alpha-synuclein production. They then tested the drugs in mice and stem cells and studied in data from the health records of millions of people living in Norway. The results of their efforts, which point to a new drug development path for PD, are published in Science.

This post comes from the RSS feed of EurekaAlert, you can find more here!

Written by admin